Warning!
Your browser does not support HTML5.
Display of the content may be incorrect.
Please make sure that your browser supports HTML5 syntax.
Structure Info
- Chemspace ID
- CSSS00000687611 (In-Stock Screening Compounds)
- CAS
- 1212345-30-6
- MFCD
- MFCD08056150, MFCD30216588
- IUPAC Name
tricyclo[3.2.1.0²,⁴]octane-3-carboxylic acid
- Mol formula
- C9H12O2
- Mol weight
- 152 Da
- Catalog Number(s)
4028852, AA0079TC, AD258415, AD39212, ADB122988001, AG0079W4, AG00J1VY, AG115567, AR007AL4, BB0219950, BBV-39926225, BD183765, CS-0271514, CSC000687611, EN300-106882, F311073, HY-W208928, JH678400, MBA39909, MYB34530, T734125, Y1337817, Z1262522712
Properties
- LogP
- 1.22
- Heavy atoms count
- 11
- Rotatable bond count
- 1
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.888
- Polar surface area (Å)
- 37
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
Supplier | Lead time | Ships from | Purity | Pack | Price, € | Qty |
Enamine Ltd | 5 days | Ukraine To: | 90 | 1 mg | 79 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 2 mg | 81 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 5 mg | 87 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 10 mg | 97 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 20 mg | 117 | |
Show all items |
ChemBridge Corp. | 14 days | United States To: | 90 | 1 mg | 68 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 3 mg | 99 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 5 mg | 99 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 10 mg | 138 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 20 mg | 209 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 25 mg | 248 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 50 mg | 407 | |
ChemBridge Corp. | 14 days | United States To: | 90 | 100 mg | 803 | |
Description: Name: tricyclo[3.2.1.0~2,4~]octane-3-carboxylic acid; Stereochemistry: unknown; Compound state: solid | |
Show all items |
For a custom pack size or bulk
please drop us a line:
Enquire
Title
By using our site chem-space.com
you agree to our use of cookies to enhance your experience.
See the Privacy Policy for more information.
OK